These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 12825097)

  • 21. Placebo-controlled study on efficacy and safety of daily apomorphine SL intake in premenopausal women affected by hypoactive sexual desire disorder and sexual arousal disorder.
    Caruso S; Agnello C; Intelisano G; Farina M; Di Mari L; Cianci A
    Urology; 2004 May; 63(5):955-9. PubMed ID: 15134988
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Apomorphine SL (Uprima): preclinical and clinical experiences learned from the first central nervous system-acting ED drug.
    Giuliano F; Allard J
    Int J Impot Res; 2002 Feb; 14 Suppl 1():S53-6. PubMed ID: 11850736
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Future directions in erectile dysfunction therapy.
    Mulhall JP
    Postgrad Med; 2000 May; 107(6 Suppl Educational):19-23. PubMed ID: 19667519
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Central mechanisms of erectile dysfunction: what a clinician may want to know.
    Stief CG
    Int J Impot Res; 2003 Apr; 15 Suppl 2():S3-6. PubMed ID: 12825096
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Apomorphine: an update of clinical trial results.
    Heaton JP
    Int J Impot Res; 2000 Oct; 12 Suppl 4():S67-73. PubMed ID: 11035390
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intranasal apomorphine. Nastech Pharmaceutical.
    Kendirci M; Hellstrom WJ
    IDrugs; 2004 May; 7(5):483-8. PubMed ID: 15154111
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of visual sexual stimuli and apomorphine SL on cerebral activity in men with erectile dysfunction.
    Hagemann JH; Berding G; Bergh S; Sleep DJ; Knapp WH; Jonas U; Stief CG
    Eur Urol; 2003 Apr; 43(4):412-20. PubMed ID: 12667723
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sequential administration enhances the effect of apomorphine SL in men with erectile dysfunction.
    Heaton JP; Dean J; Sleep DJ
    Int J Impot Res; 2002 Feb; 14(1):61-4. PubMed ID: 11896482
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Update on oral treatments for male erectile dysfunction.
    Kalsi JS; Kell PD
    J Eur Acad Dermatol Venereol; 2004 May; 18(3):267-74. PubMed ID: 15096134
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy and safety of daily intake of apomorphine SL in men affected by erectile dysfunction and mild hyperprolactinemia: a prospective, open-label, pilot study.
    Caruso S; Intelisano G; Farina M; DiMari L; Agnello C; Giammusso B
    Urology; 2003 Nov; 62(5):922-7. PubMed ID: 14624921
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Safety and tolerability of apomorphine SL in patients with erectile dysfunction.
    Buvat J; Montorsi F
    BJU Int; 2001 Oct; 88 Suppl 3():30-5. PubMed ID: 11578277
    [No Abstract]   [Full Text] [Related]  

  • 32. Central nervous system agents in the treatment of erectile dysfunction.
    Kendirci M; Walls MM; Hellstrom WJ
    Urol Clin North Am; 2005 Nov; 32(4):487-501, vii. PubMed ID: 16291040
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Apomorphine to Uprima: the development of a practical erectogenic drug: a personal perspective.
    Morales A
    Int J Impot Res; 2001 Aug; 13 Suppl 3():S29-34. PubMed ID: 11477489
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Apomorphine sublingual as primary or secondary treatment for erectile dysfunction in patients with spinal cord injury.
    Strebel RT; Reitz A; Tenti G; Curt A; Hauri D; Schurch B
    BJU Int; 2004 Jan; 93(1):100-4. PubMed ID: 14678378
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Experiences with apomorphine SL in studies: tolerated therapy--even in problem patients].
    MMW Fortschr Med; 2002 May; Suppl 2():83. PubMed ID: 12070860
    [No Abstract]   [Full Text] [Related]  

  • 36. New oral agents for erectile dysfunction: what is changing in our practice?
    Aversa A; Fabbri A
    Asian J Androl; 2001 Sep; 3(3):175-9. PubMed ID: 11561186
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [New treatment options for erectile dysfunction. Pharmacologic and nonpharmacologic options].
    Sperling H; Lümmen G; Schneider T; Rübben H
    Herz; 2003 Jun; 28(4):314-24. PubMed ID: 12825147
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An open-label, randomized, flexible-dose, crossover study to assess the comparative efficacy and safety of sildenafil citrate and apomorphine hydrochloride in men with erectile dysfunction.
    Eardley I; Wright P; MacDonagh R; Hole J; Edwards A
    BJU Int; 2004 Jun; 93(9):1271-5. PubMed ID: 15180621
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mode of action of a new oral treatment for erectile dysfunction: apomorphine SL.
    Rampin O
    BJU Int; 2001 Oct; 88 Suppl 3():22-4. PubMed ID: 11578275
    [No Abstract]   [Full Text] [Related]  

  • 40. Apomorphine (TAP holdings). 6a beta-aporphine-10,11-diol hydrochloride hemihydrate, apomorphine hydrochloride, spontane, Uprima.
    Drugs R D; 1999 Dec; 2(6):415-6. PubMed ID: 10763454
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.